CSN8 could serve as another potential prognostic biomarker in CRC and an ideal target for the elimination of disseminated quiescent cells, thereby reducing the risk of tumor metastasis and recurrence and chemoresistance prevention [19]. Here, COPS8 is linked to neoplasm.